Group A streptococcal infection

And if this is the first time you're listening to Let's Talk Micro, well, thank you for making it one of your podcasts.

Okay, so today's episode is about Group A strep, more specifically about the IDSA, Infectious Diseases Society of America, guidelines that were released in 2025 regarding Group A streptococcal pharyngitis.

And these guidelines focus on diagnostic stewardship.

So in this episode, I am joined by Dr. Christopher Dorn to discuss these guidelines.

And the Let's Talk Micro podcast is supported by the American Society for Microbiology.

To learn more about microbes, visit asm.org. And that micro friends, it's the end of this episode.

I hope you enjoy learning about the group A streptococcal pharyngitis guidelines.

released by the IDSA.

... or...

It's called IGAS, Invasive Group A Strep, and yeah, it's...

She was in the ICU for, like, uh, a, a solid week.

She was in the hospital for a really long time.

A total of 17 diseases caused by bacteria, viruses and parasites could be treated far more successfully with the right vaccines, the WHO said.

These include Group A Streptococcus bacteria that cause skin, soft tissue and respiratory tract infections, and Klebsiella pneumonia bacteria, which are commonly found in our intestines but can develop into superbugs.

These two pathogens are top disease control priorities in all regions, WHO said, in addition to HIV, malaria and tuberculosis, which together cause nearly 2.5 million deaths every year.

Dr Kate O'Brien, WHO's director of immunisation, vaccines and biologicals, said that too often, global decisions on new vaccines have been solely driven by return on investment, rather than by the number of lives that could be saved.